In view of the fact that hepassocin causes hepatic steatosis and induces IR, and because CKD has a clear association with both hepatic steatosis and type 2 diabetes 14,15, the authors postulated that hepassocin might be the link between these diseases. This evidence concerns the gene FGL1 and chronic kidney disease.